ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

13,023Medicare Part D Prescriptions Filled, Including Refills

Rank: 54 out of 973

$544K Total Retail Price of All Prescriptions

Rank: 114 out of 973

456 Patients Receiving at Least One Drug in Part D
91%Patients 65 Years and Older
30% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Kansas
Lower avg

Schedule Two
Controlled Substances

5% of this provider’s 456 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

14% of this provider’s 456 patients filled at least one prescription for a schedule three drug, compared to an average of 14%.

Risky Drugs to Seniors

2% of this provider’s 12,336 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

20% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$42 was the average price of a prescription from this provider, compared to $51 among peers.

Prescriptions per Patient

29 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Kansas
OMEPRAZOLE 597 571 1 5
SIMVASTATIN 531 513 2 1
LEVOTHYROXINE SODIUM 518 504 3 2
LISINOPRIL 505 505 4 3
POTASSIUM CHLORIDE 406 374 5 9
AMLODIPINE BESYLATE 403 403 6 7
HYDROCHLOROTHIAZIDE 398 396 7 11
METOPROLOL TARTRATE 375 372 8 13
FUROSEMIDE 374 360 9 6
CITALOPRAM HBR 309 291 10 14
WARFARIN SODIUM 285 282 11 10
HYDROCODONE-ACETAMINOPHEN 266 248 S3 12 4
ATENOLOL 259 255 13 16
LOSARTAN POTASSIUM 237 231 14 19
METOPROLOL SUCCINATE 220 210 15 17
METFORMIN HCL 217 203 16 8
ENALAPRIL MALEATE 208 201 17 55
ALENDRONATE SODIUM 149 149 18 24
NAMENDA 146 146 19 31
SPIRONOLACTONE 142 139 20 49
ZOLPIDEM TARTRATE 128 113 21 20
RISPERIDONE 125 108 22 65
GABAPENTIN 124 122 23 12
GLIPIZIDE 122 120 24 69
DIGOXIN 114 108 25 32
DONEPEZIL HCL 107 105 26 26
ATORVASTATIN CALCIUM 105 105 27 15
TRIAMTERENE-HCTZ 102 98 28 51
CLOPIDOGREL 97 97 29 44
POLYETHYLENE GLYCOL 3350 92 89 30 36
VENLAFAXINE HCL ER 92 89 30 95
OXYBUTYNIN CHLORIDE 91 77 32 92
PRAVASTATIN SODIUM 89 89 33 22
LOSARTAN-HYDROCHLOROTHIAZIDE 88 70 34 46
AZITHROMYCIN 80 77 35 47
TEKTURNA 75 75 36 230
PROAIR HFA 71 41 37 54
VYTORIN 70 70 38 154
PROPRANOLOL HCL 70 64 38 97
IBUPROFEN 65 47 40 102
CRESTOR 65 65 40 34
MELOXICAM 64 55 42 23
CHLORTHALIDONE 62 62 43 156
ALLOPURINOL 61 55 44 29
PLAVIX 60 60 45 78
FELODIPINE ER 60 60 45 210
ESCITALOPRAM OXALATE 57 57 47 68
TRAZODONE HCL 57 46 47 48
DIOVAN 55 55 49 63
EVISTA 54 54 50 121
ISOSORBIDE MONONITRATE ER 54 54 50 85
CELEBREX 53 40 52 91
CYMBALTA 53 41 52 40
SYMBICORT 53 36 52 163
TAMSULOSIN HCL 52 52 55 28
PAROXETINE HCL 52 48 55 66
VENLAFAXINE HCL 52 50 55 192
TRAMADOL HCL 51 44 58 18
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.